Nov 17
3rd Gen Sequencing company PacBio reveals commercial specs
In today’s edition of In Sequence, editor Julia Karow, revealed a number of performance specifications for PacBio’s first commercial single-molecule real-time DNA sequencer, due to be released during the second half of 2010.
PacBio CEO, Hugh Martin, states:
Our pricing strategy, at this time, is that we are going to probably fix a $100 per-run cost. Over time, that price is going to remain the same, but the amount of sequence that you will get for that $100 will go up tremendously. The minimum run time is between 10 and 15 minutes, which users can adjust, depending on whether they want to maximize their throughput or read length. An entire experiment, from the time that you start sample prep to when you have your data, can be completed in less than 12 hours.
Click to read the entire article at In Sequence (requires subscription)
November 18th, 2009 at 01:54
Social comments and analytics for this post…
This post was mentioned on Twitter by CLCbio: 3rd Gen Sequencing company PacBio reveals commercial specs: http://bit.ly/2ZwXSk #pacbio #smrt…
November 21st, 2009 at 05:19
[...] released some specs through GenomeWeb’s In Sequence and what I’ve been able to scrounge about (I can’t quite talk myself into asking for a subscription) this is going to put some real [...]